Buscapina Tablet, Film Coated
NDC Package 69729-813-24

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Buscapina (acetaminophen, caffeine and pyrilamine maleate) tablets is do not exceed recommended dosageadults and children 12 years and over; take 2 caplets with water. This formulation utilizes a tablet, film coated delivery system. Marketed by Opmx Llc, this product is identified by NDC 69729-813 and is authorized under FDA application M013.

Identification & Billing

NDC Package Code
69729-813-24
Package Description
2 BLISTER PACK in 1 CARTON / 12 TABLET, FILM COATED in 1 BLISTER PACK
Product Code
69729-813
11-Digit Billing Format
69729081324

Clinical Specifications

Proprietary Name
Buscapina
Non-Proprietary Name
Acetaminophen, Caffeine And Pyrilamine Maleate
Substance Name
Acetaminophen; Caffeine; Pyrilamine Maleate
Dosage Form
Tablet, Film Coated - A solid dosage form that contains medicinal substances with or without suitable diluents and is coated with a thin layer of a water-insoluble or water-soluble polymer.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
Pharmacologic Class
Usage Information
Do not exceed recommended dosageadults and children 12 years and over; take 2 caplets with water. Repeat every 6 hours, as needed. Do not exceed 6 caplets per day.children under 12 years: consult a doctor

Regulatory & Marketing

Labeler Name
Opmx Llc
Product Type
Human Otc Drug
FDA Application #
M013
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
11-12-2025
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 69729-813-24 identifies a specific commercial package of 2 blister pack in 1 carton / 12 tablet, film coated in 1 blister pack of Buscapina, a human over the counter drug labeled by Opmx Llc. This tablet, film coated is formulated for oral use and contains acetaminophen; caffeine; pyrilamine maleate as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Opmx Llc on November 12, 2025. The current certification is valid through December 31, 2026.

How is this Opmx Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 69729081324. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
69729-813-24
11-Digit CMS (5-4-2)
69729-0813-24

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.